Heard on the Street: There is areal opportunity for pill-form peptides to hit big pharma’s most profitable franchises https://t.co/fv76VkX5VL
Why now
Thesis: Oral peptides could disrupt big pharma injectable franchises
Catalyst to watch: Clinical trial results or FDA filings
Main risk: Oral delivery may fail in trials
Why it matters
Pill-form peptides could disrupt injectable franchises, reshaping big pharma's most profitable markets.
Details
Heard on the Street: There is areal opportunity for pill-form peptides to hit big pharma’s most profitable franchises https://t.co/fv76VkX5VL
Sources
- x · 2026-09-25 09:32 UTC